Use of avexitide in patients with post-bariatric hypoglycaemia and hyperinsulinemic hypoglycaemia
Phase 2b results of avexitide (Eiger BioPharmaceuticals) in patients with post-bariatric hypoglycemia (PBH) and hyperinsulinemic...
top of page
Browse by category
Search
PREVENT Study: Positive results of Avexitide in post-bariatric hypoglycaemia patients
Eiger BioPharmaceuticals has announced positive results from the Phase 2 PREVENT study of Avexitide in patients with severe...
Browse by tag
bottom of page